# Biosphere Biosphere is a biomanufacturing company that designs and operates UV-sterilized bioreactors to enable scaled production of bioproducts including food, medicine, textiles, and chemicals. The company emerged from stealth in 2025 with fully operational UV bioreactor systems available to technology partners for trial runs and manufacturing services, targeting bioproduct companies with $10–100M annual recurring revenue seeking to scale production 100x. Biosphere's core technology replaces traditional steam sterilization with UV radiation and advanced materials, reducing costs and complexity while increasing scalability for fermentation-based manufacturing. The company was founded in 2022 by Brian Heligman and Arye Lipman. Biosphere raised funding from Lower Carbon, VXI Capital, Founders Fund, and GS Futures. The company is developing a commercial-scale facility with capacity ranging from 100 to 1000 cubic meters.